Novo Nordisk/€NOVOB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Novo Nordisk
Novo Nordisk A/S is a global healthcare company headquartered in Bagsværd, Denmark, that operates in the pharmaceutical industry with a primary focus on diabetes care. The company develops, manufactures, and markets pharmaceutical products and services, with significant emphasis on insulin and GLP-1 therapy for diabetes management. Novo Nordisk is also involved in the treatment of obesity, rare blood and endocrine disorders, and growth hormone therapy. The company was founded in 1923 and has a substantial international presence, offering products in more than 170 countries. Novo Nordisk's strategic strengths include its extensive research and development capabilities, a strong product pipeline, and a deep commitment to innovation in chronic disease management.
Ticker
€NOVOB
Sector
Primary listing
XGAT
Employees
67,900
Headquarters
Bagsvaerd, Denmark
Website
Novo Nordisk Metrics
BasicAdvanced
€170bn
10.37
€3.67
0.35
€1.57
4.12%
Price and volume
Market cap
€170bn
Beta
0.35
52-week high
€71.55
52-week low
€30.25
Average daily volume
388k
Dividend rate
€1.57
Financial strength
Current ratio
0.788
Quick ratio
0.541
Long term debt to equity
58.687
Total debt to equity
72.086
Dividend payout ratio (TTM)
42.47%
Interest coverage (TTM)
38.38%
Profitability
EBITDA (TTM)
23,262.87
Gross margin (TTM)
83.20%
Net profit margin (TTM)
37.20%
Operating margin (TTM)
49.25%
Effective tax rate (TTM)
21.66%
Revenue per employee (TTM)
€646,200
Management effectiveness
Return on assets (TTM)
19.25%
Return on equity (TTM)
71.40%
Valuation
Price to earnings (TTM)
10.371
Price to revenue (TTM)
3.854
Price to book
6.28
Price to tangible book (TTM)
17.44
Price to free cash flow (TTM)
40.897
Free cash flow yield (TTM)
2.45%
Free cash flow per share (TTM)
0.93
Dividend yield (TTM)
4.12%
Growth
Revenue change (TTM)
8.13%
Earnings per share change (TTM)
16.75%
3-year revenue growth (CAGR)
20.30%
10-year revenue growth (CAGR)
11.54%
3-year earnings per share growth (CAGR)
26.65%
10-year earnings per share growth (CAGR)
15.10%
3-year dividend per share growth (CAGR)
23.58%
10-year dividend per share growth (CAGR)
13.84%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs